David Clemmer, Indiana University
Mark Cockett, Bristol-Myers Squibb
Dalia Cohen, Novartis Institutes for Biomedical Research
Claire Fraser, The Institute for Genomic Research
Sandra Glucksmann, Millennium Pharmaceuticals
Rod MacKenzie, Pfizer Discovery Technology Center
Jill Mesirov, Whitehead Institute/ MIT Center for Genome Research
Emanuel Petricoin, FDA-NCI Clinical Proteomics Program
Gerald Rubin, Howard Hughes Medical Institute
Tom Tuschl, Rockefeller University